Identification and Pathogenicity of Malassezia Species Isolated from Human Healthy Skin and with Macules
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Diagnosis and Treatment of Tinea Versicolor Ronald Savin, MD New Haven, Connecticut
■ CLINICAL REVIEW Diagnosis and Treatment of Tinea Versicolor Ronald Savin, MD New Haven, Connecticut Tinea versicolor (pityriasis versicolor) is a common imidazole, has been used for years both orally and top superficial fungal infection of the stratum corneum. ically with great success, although it has not been Caused by the fungus Malassezia furfur, this chronical approved by the Food and Drug Administration for the ly recurring disease is most prevalent in the tropics but indication of tinea versicolor. Newer derivatives, such is also common in temperate climates. Treatments are as fluconazole and itraconazole, have recently been available and cure rates are high, although recurrences introduced. Side effects associated with these triazoles are common. Traditional topical agents such as seleni tend to be minor and low in incidence. Except for keto um sulfide are effective, but recurrence following treat conazole, oral antifungals carry a low risk of hepato- ment with these agents is likely and often rapid. toxicity. Currently, therapeutic interest is focused on synthetic Key Words: Tinea versicolor; pityriasis versicolor; anti “-azole” antifungal drugs, which interfere with the sterol fungal agents. metabolism of the infectious agent. Ketoconazole, an (J Fam Pract 1996; 43:127-132) ormal skin flora includes two morpho than formerly thought. In one study, children under logically discrete lipophilic yeasts: a age 14 represented nearly 5% of confirmed cases spherical form, Pityrosporum orbicu- of the disease.3 In many of these cases, the face lare, and an ovoid form, Pityrosporum was involved, a rare manifestation of the disease in ovale. Whether these are separate enti adults.1 The condition is most prevalent in tropical tiesN or different morphologic forms in the cell and semitropical areas, where up to 40% of some cycle of the same organism remains unclear.: In the populations are affected. -
Mycology Proficiency Testing Program
Mycology Proficiency Testing Program Test Event Critique January 2013 Mycology Laboratory Table of Contents Mycology Laboratory 2 Mycology Proficiency Testing Program 3 Test Specimens & Grading Policy 5 Test Analyte Master Lists 7 Performance Summary 11 Commercial Device Usage Statistics 15 Mold Descriptions 16 M-1 Exserohilum species 16 M-2 Phialophora species 20 M-3 Chrysosporium species 25 M-4 Fusarium species 30 M-5 Rhizopus species 34 Yeast Descriptions 38 Y-1 Rhodotorula mucilaginosa 38 Y-2 Trichosporon asahii 41 Y-3 Candida glabrata 44 Y-4 Candida albicans 47 Y-5 Geotrichum candidum 50 Direct Detection - Cryptococcal Antigen 53 Antifungal Susceptibility Testing - Yeast 55 Antifungal Susceptibility Testing - Mold (Educational) 60 1 Mycology Laboratory Mycology Laboratory at the Wadsworth Center, New York State Department of Health (NYSDOH) is a reference diagnostic laboratory for the fungal diseases. The laboratory services include testing for the dimorphic pathogenic fungi, unusual molds and yeasts pathogens, antifungal susceptibility testing including tests with research protocols, molecular tests including rapid identification and strain typing, outbreak and pseudo-outbreak investigations, laboratory contamination and accident investigations and related environmental surveys. The Fungal Culture Collection of the Mycology Laboratory is an important resource for high quality cultures used in the proficiency-testing program and for the in-house development and standardization of new diagnostic tests. Mycology Proficiency Testing Program provides technical expertise to NYSDOH Clinical Laboratory Evaluation Program (CLEP). The program is responsible for conducting the Clinical Laboratory Improvement Amendments (CLIA)-compliant Proficiency Testing (Mycology) for clinical laboratories in New York State. All analytes for these test events are prepared and standardized internally. -
In Vitro Activity of Phytosphingosines Against Malassezia Furfur and Candida Albicans*
Acta Derm Venereol 2002; 82: 170–173 INVESTIGATIVE REPORT In vitro Activity of Phytosphingosines against Malassezia furfur and Candida albicans* PIETRO NENOFF and UWE-FRITHJOF HAUSTEIN Department of Dermatology, University of Leipzig, Leipzig, Germany Long-chain sphingoid bases, e.g. phytosphingosine , sphin- metabolic changes: the phospholipids are degradaded gosine and sphinganine, main constituents of the stratum into glycerol and free fatty acids, and glucosylsphingo- corneum, can strongly inhibit the growth of microorgan- lipids into ceramides (2). isms that are known to have undesirable eVects on the Long chain sphingoid bases, e.g. phytosphingosines skin. The aim of this study was to investigate the in vitro (PS), sphingosines, and sphinganines are known to be activity of diVerent phytosphingosine preparations against present in the stratum corneum in free form but also as Malassezia furfur, and, in comparison, against the components of ceramides. These molecules are potent common facultative pathogenic yeast Candida albicans. inhibitors of protein kinase C and as a consequence An agar dilution test for minimum inhibitory concentration they seem to be involved in the diVerentiation of epi- (MIC ) investigation of phytosphingosin e base, phyto- dermal keratinocytes. There are also reports suggesting sphingosine lactic acid salt, phytosphingosine HCl, and that sphingoid bases play an important role in regulating phytosphingosin e glycolic acid salt was carried out using the micro- ora of the skin. D.S.T. agar containing 2% olive oil and 0.2% Tween 80, It was shown that PS, the most abundant free sphin- to allow growth of the lipophilic yeast. M. furfur growth goid base in the stratum corneum, could strongly inhibit inhibition in vitro could be achieved only at extremely the growth of microorganisms which are known to have high phytosphingosin e concentrations. -
Fungi and Allergic Lower Respiratory Tract Diseases
Clinical reviews in allergy and immunology Series editors: Donald Y. M. Leung, MD, PhD, and Dennis K. Ledford, MD Fungi and allergic lower respiratory tract diseases Alan P. Knutsen, MD,a Robert K. Bush, MD,b Jeffrey G. Demain, MD,c David W. Denning, FRCP, FMedSci,d Anupma Dixit, PhD, MPH,e Abbie Fairs, MD,f Paul A. Greenberger, MD,g Barbara Kariuki, BS, MPH,a Hirohito Kita, MD,h Viswanath P. Kurup, PhD,i Richard B. Moss, MD,j Robert M. Niven, MD,d Catherine H. Pashley, MD,f Raymond G. Slavin, MD,e Hari M. Vijay, PhD, MPH,k and Andrew J. Wardlaw, MDf St Louis, Mo, Madison and Milwaukee, Wis, Anchorage, Alaska, Manchester and Leicester, United Kingdom, Chicago, Ill, Rochester, Minn, Palo Alto, Calif, and Ottawa, Ontario, Canada INFORMATION FOR CATEGORY 1 CME CREDIT Credit can now be obtained, free for a limited time, by reading the review PhD, Richard B. Moss, MD, Robert M. Niven, MD, Catherine H. Pashley, articles in this issue. Please note the following instructions. MD, Raymond G. Slavin, MD, Hari M. Vijay, PhD, MPH, and Andrew J. Method of Physician Participation in Learning Process: The core ma- Wardlaw, MD terial for these activities can be read in this issue of the Journal or online at Activity Objectives the JACI Web site: www.jacionline.org. The accompanying tests may only 1. To describe the most common environmental factors affecting fungal be submitted online at www.jacionline.org. Fax or other copies will not be spore dispersal . accepted. 2. To list the diagnostic criteria for allergic bronchopulmonary aspergil- Date of Original Release: February 2012. -
The Role of L-DOPA on Melanization and Mycelial Production in Malassezia Furfur
The Role of L-DOPA on Melanization and Mycelial Production in Malassezia Furfur Sirida Youngchim1*, Joshua D. Nosanchuk2, Soraya Pornsuwan3, Susumu Kajiwara4, Nongnuch Vanittanakom1 1 Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, 2 Departments of Medicine (Infectious Diseases) and Microbiology/ Immunology, Albert Einstein College of Medicine, Bronx, New York, United States of America, 3 Department of Physical Chemistry, Faculty of Science, Mahidol University, Bangkok, Thailand, 4 Department of Life Science, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan Abstract Melanins are synthesized by organisms of all biological kingdoms and comprise a heterogeneous class of natural pigments. Certain of these polymers have been implicated in the pathogenesis of several important human fungal pathogens. This study investigated whether the fungal skin pathogen Malassezia furfur produces melanin or melanin-like compounds. A melanin-binding monoclonal antibody (MAb) labelled in vitro cultivated yeast cells of M. furfur. In addition, melanization of Malassezia yeasts and hyphae was detected by anti-melanin MAb in scrapings from patients with pityriasis versicolor. Treatment of Malassezia yeasts with proteolytic enzymes, denaturant and concentrated hot acid yielded dark particles and electron spin resonance spectroscopy revealed that these particles contained a stable free radical compound, consistent with their identification as melanins. Malassezia yeasts required phenolic compounds, such as L-DOPA, in order to synthesize melanin. L-DOPA also triggered hyphal formation in vitro when combined with kojic acid, a tyrosinase inhibitor, in a dose-dependent manner. In this respect, L-DOPA is thought to be an essential substance that is linked to both melanization and yeast-mycelial transformation in M. -
Development of an in Vitro Diagnostic Technique for Malassezia
Development of an In Vitro Diagnostic Technique for Malassezia furfur A thesis submitted in partial fulfilment of the requirement for the Degree of Master of Science in Microbiology in the University of Canterbury by Stephanie Fiona ~uick University of Canterbury vw+ of Contents 1 ! :) TABLE OF CONTENTS Ta hie of Contents ............................................................ 8 •••••••• 0 ••• "." ••••••••••• 1 List of Tables ............................. o ••••••• o ••••••••••••••••••••••••••••• 0 •••••••••• 0 •••••••••••••• 7 List of Figures ........................................................................................... 8 Abstract............................. o ••••• 0 ••• 0' ••••••••••••••••••••••••••••••••••••••••••••••••••••• 00 •••••• 9 Acknowledgemen ts ..... o ••••• e •••••••••••• e •••••••••••••••••••••••••••••••••••••••• o ••••• o ••••••• e •• l 0 1. INTRODUCTION .o, •• o •••••••• e •••• O' •••• O •••••••••••••••••••••••••••••••••••••••••••••••••••••• 11 1.1 THE GENUS MALASSEZIA ..................................................................... 11 1.2 TAXONOMY OF MALASSEZIA FURFUR .................................................. 12 1.3 MORPHOLOGy .................................................................................... 15 1.4 PATHOGENICITY ................................................................................. 18 1.5 fIABITAT ............................................................................................ 20 1.6 GROWTH OF MALASSEZIA FURFUR IN VITRO ........................................ -
Mold and Human Health: Separating the Wheat from the Chaff
Clinic Rev Allerg Immunol (2010) 38:148–155 DOI 10.1007/s12016-009-8175-5 Mold and Human Health: Separating the Wheat from the Chaff H. David Pettigrew & Carlo F. Selmi & Suzanne S. Teuber & M. Eric Gershwin Published online: 28 August 2009 # Humana Press Inc. 2009 Abstract The term “mold” is utilized to define the visible multicellular filaments, commonly subdivided in ubiquitous fungal species commonly found in household Ascomycota, Deuteromycota, and Zygomycota. Molds do dust and observed as visible multicellular filaments. Several not utilize photosynthesis but metabolize organic compounds well-defined human diseases are known to be caused or by secreting hydrolytic enzymes to obtain energy and thus exacerbated by mold or by exposure to their byproducts. recycle nutrients within ecosystems. Molds are currently Among these, a solid connection has been established with crucial in the production of food (i.e., cheese, bread, sausage, infections, allergic bronchopulmonary aspergillosis, allergic soy sauce, alcoholic beverages) and medications (i.e., peni- fungal rhinosinusitis, hypersensitivity pneumonitis, and cillin, cyclosporine, lovastatin). Molds are pervasive in nature, asthma. In the past decades, other less-defined and and their spores are commonly found in household dust, generally false conditions have also been ascribed to mold. particularly when favorable humidity conditions are present. We will herein review and critically discuss the available Only for a few mold species has a causative link with evidence on the influence of mold on human health. human disease been established; in these cases, signs and symptoms are usually pathognomonic. Recently, there has Keywords Mold . Human diseases . Fungi kingdom been an expansion in the number of conditions putatively ascribed to mold, thus leading to the concept of “mold toxicity” attributed to mycotoxins or irritants derived from Mold and fungi fungi. -
Pathology of Fungal Infection
14/10/56 Pathology of Fungal Infection Julintorn Somran, MD. Growth form of fungi Filamentous or hyphae Yeasts 1 14/10/56 Dimorphic fungi • Presence of both filamentous forms and yeasts in their cycle – Histoplasma spp. • Hyphae at environmental temperatures and yeast form in the body – Candida spp. • Hyphae, pseudohyphae, and yeast form in the body Three types of fungal infection (Mycoses) 1. Superficial mycoses: – Skin, hair, and nails 2. Cutaneous and Subcutaneous mycoses: – deeper layer of skin 3. Systemic or deep mycoses: – internal organ involvement – Including opportunistic infection 2 14/10/56 Superficial mycoses Tinea (Ringworm) Ptyriasis versicolor Cutaneous and Subcutaneous mycoses Eumycotic mycetoma 3 14/10/56 Systemic or deep mycoses Mucormycosis or Zygomycosis Systemic or deep mycoses Pulmonary aspergilllosis 4 14/10/56 Host – Agent relationship Immunocompetent Nosocomial host infection Pathogenic agents Environment Organisms Host Infectious disease Impaired Defense mechanism Immunocompromise Opportunistic host infection Superficial mycoses Representative Causative Growth form disease organisms in Tissue Dermatophytosis Microsporum, Filamentous form Trichophyton, and Epidermophyton Pityriasis versicolor or Malassezia Yeast and filamentous skin infection via form malassezia Tinea nigra or Exophialia Filamentous form keratomycosis nigrican (Phaeoanellomyces) (pigmented) palmaris wernekii Onychomycosis Microsporum, Filamentous form Trichophyton, Epidermophyton etc. 5 14/10/56 DERMATOPHYTOSIS • Definition and Epidemiology: – Common superficial infection caused by fungi that able to invade keratinized tissue – stratum corneum, hair, and nails. – World wide in distribution – The source of infection – another person, animal or soil • Etiologic agents: – Microsporum, Trichophyton, and Epidermophyton – T rubrum – most common for tinea pedis and onychomycosis in temperate climate, and tinea cruris and tinea corporis in the tropics. -
Gene Function Analysis in the Ubiquitous Human Commensal and Pathogen Malassezia Genus
RESEARCH ARTICLE crossmark Gene Function Analysis in the Ubiquitous Human Commensal and Pathogen Malassezia Genus Giuseppe Ianiri,a Anna F. Averette,a Joanne M. Kingsbury,a,b Joseph Heitman,a Alexander Idnurmc Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USAa; The Institute of Environmental Science and Research, Christchurch, New Zealandb; School of BioSciences, University of Melbourne, Victoria, Australiac ABSTRACT The genus Malassezia includes 14 species that are found on the skin of humans and animals and are associated with a number of diseases. Recent genome sequencing projects have defined the gene content of all 14 species; however, to date, ge- netic manipulation has not been possible for any species within this genus. Here, we develop and then optimize molecular tools for the transformation of Malassezia furfur and Malassezia sympodialis using Agrobacterium tumefaciens delivery of transfer DNA (T-DNA) molecules. These T-DNAs can insert randomly into the genome. In the case of M. furfur, targeted gene replace- ments were also achieved via homologous recombination, enabling deletion of the ADE2 gene for purine biosynthesis and of the LAC2 gene predicted to be involved in melanin biosynthesis. Hence, the introduction of exogenous DNA and direct gene manip- ulation are feasible in Malassezia species. IMPORTANCE Species in the genus Malassezia are a defining component of the microbiome of the surface of mammals. They are also associated with a wide range of skin disease symptoms. Many species are difficult to culture in vitro, and although genome sequences are available for the species in this genus, it has not been possible to assess gene function to date. -
The Spectrum of Malassezia Infections in the Bone Marrow Transplant Population
Bone Marrow Transplantation (2000) 26, 645–648 2000 Macmillan Publishers Ltd All rights reserved 0268–3369/00 $15.00 www.nature.com/bmt The spectrum of Malassezia infections in the bone marrow transplant population VA Morrison1,2 and DJ Weisdorf1 1Bone Marrow Transplant Unit, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA Summary: Malassezia consists of seven species, most human infec- tions are caused by Malassezia furfur, which includes the A consecutive series of 3044 patients who underwent species previously known as Pityrosporum ovale and BMT at the University of Minnesota over a 25 year per- Pityrosporum orbicularae.6–9 Sporadic cases of fungemia, iod were reviewed for the post-transplant occurrence of meningitis, urinary tract infection, and cutaneous infection infection caused by the yeast Malassezia furfur. Six caused by Malassezia pachydermatis have been patients, ranging in age from 1 to 54 years, developed reported.10,11 Malassezia sympodialis is an unusual cause Malassezia infections at a median of 59 days post trans- of human infection.12 These dimorphic saprophytic yeast plant. Five patients were allogeneic transplant recipi- isolates are known to have unusual lipophilic growth ents; the remaining patient had undergone autologous requirements, in that growth occurs on standard fungal transplantation. A spectrum of clinical manifestations media such as Sabouraud dextrose agar only when the cul- of Malassezia infection was seen in these patients, ture medium is supplemented with a source of including infections of mucosal surfaces and the skin, in medium/long-chain fatty acids. Although a variety of Mal- addition to catheter-related fungemia. -
Descriptions of Medical Fungi
DESCRIPTIONS OF MEDICAL FUNGI THIRD EDITION (revised November 2016) SARAH KIDD1,3, CATRIONA HALLIDAY2, HELEN ALEXIOU1 and DAVID ELLIS1,3 1NaTIONal MycOlOgy REfERENcE cENTRE Sa PaTHOlOgy, aDElaIDE, SOUTH aUSTRalIa 2clINIcal MycOlOgy REfERENcE labORatory cENTRE fOR INfEcTIOUS DISEaSES aND MIcRObIOlOgy labORatory SERvIcES, PaTHOlOgy WEST, IcPMR, WESTMEaD HOSPITal, WESTMEaD, NEW SOUTH WalES 3 DEPaRTMENT Of MOlEcUlaR & cEllUlaR bIOlOgy ScHOOl Of bIOlOgIcal ScIENcES UNIvERSITy Of aDElaIDE, aDElaIDE aUSTRalIa 2016 We thank Pfizera ustralia for an unrestricted educational grant to the australian and New Zealand Mycology Interest group to cover the cost of the printing. Published by the authors contact: Dr. Sarah E. Kidd Head, National Mycology Reference centre Microbiology & Infectious Diseases Sa Pathology frome Rd, adelaide, Sa 5000 Email: [email protected] Phone: (08) 8222 3571 fax: (08) 8222 3543 www.mycology.adelaide.edu.au © copyright 2016 The National Library of Australia Cataloguing-in-Publication entry: creator: Kidd, Sarah, author. Title: Descriptions of medical fungi / Sarah Kidd, catriona Halliday, Helen alexiou, David Ellis. Edition: Third edition. ISbN: 9780646951294 (paperback). Notes: Includes bibliographical references and index. Subjects: fungi--Indexes. Mycology--Indexes. Other creators/contributors: Halliday, catriona l., author. Alexiou, Helen, author. Ellis, David (David H.), author. Dewey Number: 579.5 Printed in adelaide by Newstyle Printing 41 Manchester Street Mile End, South australia 5031 front cover: Cryptococcus neoformans, and montages including Syncephalastrum, Scedosporium, Aspergillus, Rhizopus, Microsporum, Purpureocillium, Paecilomyces and Trichophyton. back cover: the colours of Trichophyton spp. Descriptions of Medical Fungi iii PREFACE The first edition of this book entitled Descriptions of Medical QaP fungi was published in 1992 by David Ellis, Steve Davis, Helen alexiou, Tania Pfeiffer and Zabeta Manatakis. -
Potential Synergistic Action of Bioactive Compounds from Plant Extracts Against Skin Infecting Microorganisms
International Journal of Molecular Sciences Review Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms Przemysław Sitarek 1,* , Anna Merecz-Sadowska 2 , Tomasz Kowalczyk 3 , Joanna Wieczfinska 4 , Radosław Zajdel 2 and Tomasz Sliwi´ ´nski 5 1 Department of Biology and Pharmaceutical Botany, Medical University of Lodz, 90-151 Lodz, Poland 2 Department of Economic Informatics, University of Lodz, 90-214 Lodz, Poland; [email protected] (A.M.-S.); [email protected] (R.Z.) 3 Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland; [email protected] 4 Department of Immunopathology, Medical University of Lodz, 90-752 Lodz, Poland; joanna.wieczfi[email protected] 5 Laboratory of Medical Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland; [email protected] * Correspondence: [email protected] Received: 26 June 2020; Accepted: 16 July 2020; Published: 19 July 2020 Abstract: The skin is an important organ that acts as a physical barrier to the outer environment. It is rich in immune cells such as keratinocytes, Langerhans cells, mast cells, and T cells, which provide the first line of defense mechanisms against numerous pathogens by activating both the innate and adaptive response. Cutaneous immunological processes may be stimulated or suppressed by numerous plant extracts via their immunomodulatory properties. Several plants are rich in bioactive molecules; many of these exert antimicrobial, antiviral, and antifungal effects. The present study describes the impact of plant extracts on the modulation of skin immunity, and their antimicrobial effects against selected skin invaders.